These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26044279)

  • 1. Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis.
    Tanoshima M; Kobayashi T; Tanoshima R; Beyene J; Koren G; Ito S
    Clin Pharmacol Ther; 2015 Oct; 98(4):417-41. PubMed ID: 26044279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.
    Kini U; Lee R; Jones A; Smith S; Ramsden S; Fryer A; Clayton-Smith J;
    Eur J Med Genet; 2007; 50(6):411-20. PubMed ID: 17951123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development.
    Shafique S; Winn LM
    Placenta; 2021 Sep; 112():141-152. PubMed ID: 34352490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
    Bosak M; Słowik A; Turaj W
    Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic Acid in Women and Girls of Childbearing Age.
    Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
    Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogenic effects of anticonvulsants.
    Paulson GW; Paulson RB
    Arch Neurol; 1981 Mar; 38(3):140-3. PubMed ID: 6781455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratology of valproic acid: an updated review of the possible mediating mechanisms.
    Ponzano A; Tiboni GM
    Minerva Ginecol; 2018 Jun; 70(3):303-322. PubMed ID: 28398022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
    Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
    BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
    Kozma C
    Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review.
    Ornoy A; Echefu B; Becker M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
    Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
    Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information.
    Martínez-Frías ML
    Am J Med Genet; 1990 Oct; 37(2):277-82. PubMed ID: 2248297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug.
    Tomson T; Battino D; Perucca E
    Lancet Neurol; 2016 Feb; 15(2):210-218. PubMed ID: 26655849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In utero exposure to valproate increases the risk of isolated cleft palate.
    Jackson A; Bromley R; Morrow J; Irwin B; Clayton-Smith J
    Arch Dis Child Fetal Neonatal Ed; 2016 May; 101(3):F207-11. PubMed ID: 26408639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid prenatal exposure. Association with lipomyelomeningocele.
    Carter BS; Stewart JM
    Clin Pediatr (Phila); 1989 Feb; 28(2):81-5. PubMed ID: 2492459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.